Recovery capacity is the missing variable most people ignore
Clinical trials commonly start with 1 mg weekly and gradually increase the dose to higher levels such as 4 mg, 8 mg, or even 12 mg depending on the study protocol
TRIUMPH-Outcomes: Long-term cardiovascular outcomes trial
When GLP-1 signaling was blocked, TC10's cognitive protective effects were significantly attenuated
In November of 2025, however, the drug's manufacturer Novo Nordisk announced a more affordable option: uninsured patients (or those who have insurance that doesn't cover Wegovy) can access all dose strengths of Wegovy injections at a reduced cash price of $349 per month via Novo Nordisk's direct-to-consumer online pharmacy, NovoCare
These conversations frequently overlap with discussions of GLP-1 off-label dosing, underscoring the importance of clinician guidance